NZME Updates FY23 Guidance

MKTUPDTE
Tue, Nov 07 2023 08:30 am

NZME Updates FY23 Guidance

AUCKLAND, 7 November 2023: NZME Limited (NZX: NZM, ASX: NZM) (“NZME”) notes that the economic environment over the past year has been challenging.

Advertising revenue for the first half of 2023 was down 7 percent year on year. Given this, NZME provided an update in August that it expected to achieve EBITDA at the bottom of the guidance range of $59 million to $64 million for 2023.

The second half has seen improvement in business confidence, but this is not yet consistently reflected in advertising revenue results:
• Quarter 3 advertising revenue was down 2 percent year on
year
• Quarter 4 started with October advertising revenue growth
of 1 percent year on year
• November (the largest revenue month of the year) and
December are currently pacing slower, with a number of
customer campaigns being cancelled or deferred until 2024

Given the current advertising revenue volatility in the market, NZME amends its guidance for EBITDA to be between $57 million and $59 million for 2023.

NZME is continuing its transition to a digital-led business and will update its shareholders at its Investor Day on 15 November 2023.


ENDS

Authorised by the Board of NZME Limited.

For further information:

For media
Kelly Gunn
GM Communications
+64 27 213 5625
[email protected]

For investors
David Mackrell
Chief Financial Officer
+64 21 311 911
[email protected]



Announcement PDF


Markets News

Pacific Edge upbeat about latest move for new test
Markets

Pacific Edge upbeat about latest move for new test

The median price for Cxbladder Triage Plus is US$1,018.44.

Markets

Pacific Edge reviews US pricing for new Cxbladder test

Cxbladder Triage Plus is a ‘next-generation’ Cxbladder test.

Pacific Edge reviews US pricing for new Cxbladder test
Infrastructure

Second Auckland airport runway pushed out to 2038

The new draft master plan will be finalised by year-end.

Second Auckland airport runway pushed out to 2038